🧠 AI clinical summary is being generated for this article and will appear shortly.
Source
NICE
Published
25 Mar 2026
Last Indexed
25 Mar 2026
Specialty
Respiratory / COPD / Asthma
NICE NG80 provides guidance on the diagnosis and management of asthma in adults and children, including updated stepwise treatment ladder and monitoring approaches.
Key Recommendations
- Diagnosis: objective evidence of reversible airflow obstruction or bronchial hyperresponsiveness
- Step 1: As-needed SABA reliever inhaler
- Step 2: Add low-dose ICS (preventer). First-line: beclomethasone 200mcg/day or equivalent
- Step 3: Add LABA to ICS (combination inhaler). If inadequate: increase ICS dose
- Step 4: Refer to specialist. Consider LTRA, theophylline, or biologic therapy
- Biologics (dupilumab, mepolizumab, benralizumab) for severe eosinophilic asthma
- Annual asthma review for all patients: adherence, inhaler technique, written action plan
ClinicalIQ Editorial Note: This guideline summary is indexed from NICE. Always refer to the full guideline for complete recommendations. Last indexed: 25 Mar 2026
More in Respiratory / COPD / Asthma
NICE
Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management (NICE NG115)
25 Mar 2026
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III…
25 Mar 2026
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in…
25 Mar 2026